Brief S2k guidelines - Merkel cell carcinoma;S2k Kurzleitlinie - Merkelzellkarzinom

JDDG - Journal of the German Society of Dermatology

Volumn 11, Issue SUPPL. 3, 2013, Pages 29-36

  Becker, Jürgen C ^a   Assaf, Chalid ^b   Vordermark, Dirk ^c   Reske, Sven N ^d   Hense, Jörg ^e   Dettenborn, Therese ^f   Seitz, Oliver ^g   Grabbe, Stephan ^h  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

^b HELIOS KLINIKUM KREFELD   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d UNIVERSITY HOSPITAL ULM   (Germany)

^e UNIVERSITY HOSPITAL ESSEN   (Germany)

^f Clinic Hornheide   (Germany)

^g UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^h UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRACYCLINE; ANTIMETABOLITE; BLEOMYCIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; PLATINUM DERIVATIVE;

ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CANCER IMMUNOTHERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURGERY; CLINICAL FEATURE; CONFLICT OF INTEREST; EXPERIMENTAL THERAPY; FOLLOW UP; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOLOGY; LUNG SMALL CELL CANCER; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MERKEL CELL POLYOMAVIRUS; MERKEL CELL TUMOR; MONOTHERAPY; MULTIMODALITY CANCER THERAPY; PRACTICE GUIDELINE; PRIMARY TUMOR; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; SATELLITE METASTASIS; SYSTEMIC THERAPY;

CARCINOMA, MERKEL CELL; DERMATOLOGY; GERMANY; HUMANS; MEDICAL ONCOLOGY; PRACTICE GUIDELINES AS TOPIC; SKIN NEOPLASMS;

EID: 84876238155     PISSN: 16100379     EISSN: 16100387     Source Type: Journal    
DOI: 10.1111/ddg.12015_6     Document Type: Article

References (54)

1. Albores-Saavedra J, Batich K, Chable- Montero F, Sagy N, Schwartz AM, Henson DE. Merkel cell carcinoma demographics, morphology, and survival based on 3 870 cases: a population based study. J Cutan Pathol 2010; 37: 20-7.
2. Schrama D, Becker JC. Merkel cell carcinoma - pathogenesis, clinical aspects and treatment. J Eur Acad Dermatol Venereol 2011; 25: 1121-9.
3. Agelli M, Clegg LX, Becker JC, Rollison DE. The etiology and epidemiology of merkel cell carcinoma. Curr Probl Cancer 2010; 34: 14-37.
4. Reichgelt BA, Visser O. Epidemiology and survival of Merkel cell carcinoma in the Netherlands. A population- based study of 808 cases in 1993-2007. Eur J Cancer 2011; 47: 579-85.
5. Zwald FO, Brown M. Skin cancer in solid organ transplant recipients: advances in therapy and management: part I. Epidemiology of skin cancer in solid organ transplant recipients. J Am Acad Dermatol 2011; 65: 253-61; quiz 262.
6. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas PF, Nghiem P. Clinical characteristics of Merkel cell carcinoma at diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol 2008; 58: 375-81.
7. Andea AA, Coit DG, Amin B, Busam KJ. Merkel cell carcinoma: histologic features and prognosis. Cancer 2008; 113: 2549-58.
8. Sidiropoulos M, Hanna W, Raphael SJ, Ghorab Z. Expression of TdT in Merkel cell carcinoma and small cell lung carcinoma. Am J Clin Pathol 2011; 135: 831-8.
9. Ames HM, Bichakjian CK, Liu GY, Oravecz-Wilson KI, Fullen DR, Verhaegen ME, Johnson TM, Dlugosz AA, Ross TS. Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit. J Invest Dermatol 2011; 131: 2113-20.
10. Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, Kraus DH, Brady MS, Coit DG. Five hundred patients with Merkel cell carcinoma evaluated at a single institution. Ann Surg 2011a; 254: 465-73; discussion 473-65.
11. Girschik J, Thorn K, Beer TW, Heenan PJ, Fritschi L. Merkel cell carcinoma in Western Australia: a population-based study of incidence and survival. Br J Dermatol 2011; 165: 1051-7.
12. Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang LC, Johnson TM, Liegeois-Kwon NJ, Otley CC, Paulson KG et al. Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5 823 cases as the basis of the first consensus staging system. J Am Acad Dermatol 2010; 63: 751-61.
13. Zager JS, Rollison DE, Messina J. Prognostication in Merkel cell carcinoma. Expert Rev Anticancer Ther 2011; 11: 665-7.
14. Paulson KG, Iyer JG, Tegeder AR, Thibodeau R, Schelter J, Koba S, Schrama D, Simonson WT, Lemos BD, Byrd DR et al. Transcriptome-wide studies of merkel cell carcinoma and validation of intratumoral CD8+ lymphocyte invasion as an independent predictor of survival. J Clin Oncol 2011; 29: 1539-46.
15. Bhatia K, Goedert JJ, Modali R, Preiss L, Ayers LW. Merkel cell carcinoma subgroups by Merkel cell polyomavirus DNA relative abundance and oncogene expression. Int J Cancer 2010; 126: 2240-6.
16. Handschel J, Muller D, Depprich RA, Ommerborn MA, Kubler NR, Naujoks C, Reifenberger J, Schafer KL, Braunstein S. The new polyomavirus (MCPyV) does not affect the clinical course in MCCs. Int J Oral Maxillofac Surg 2010; 39: 1086-90.
17. Schrama D, Peitsch WK, Zapatka M, Kneitz H, Houben R, Eib S, Haferkamp S, Moore PS, Shuda M, Thompson JF et al. Merkel cell polyomavirus status is not associated with clinical course of merkel cell carcinoma. J Invest Dermatol 2011; 131: 1631-8.
18. Sihto H, Kukko H, Koljonen V, Sankila R, Bohling T, Joensuu H. Clinical factors associated with Merkel cell polyomavirus infection in Merkel cell carcinoma. J Natl Cancer Inst 2009; 101: 938-45.
19. Bichakjian CK, Lowe L, Lao CD, Sandler HM, Bradford CR, Johnson TM, Wong SL. Merkel cell carcinoma: critical review with guidelines for multidisciplinary management. Cancer 2007; 110: 1-12.
20. Concannon R, Larcos GS, Veness M. The impact of (18)F-FDG PET-CT scanning for staging and management of Merkel cell carcinoma: results from Westmead Hospital, Sydney, Australia. J Am Acad Dermatol 2010; 62: 76-84.
21. Golan H, Volkov O, Linchinsky O, Melloul M. FDG-PET imaging in Merkel cell carcinoma - value of head-to-toe scan. Nucl Med Rev Cent East Eur 2005; 8: 135-6.
22. Peloschek P, Novotny C, Mueller- Mang C, Weber M, Sailer J, Dawid M, Czerny C, Dudczak R, Kletter K, Becherer A. Diagnostic imaging in Merkel cell carcinoma: lessons to learn from 16 cases with correlation of sonography, CT, MRI and PET. Eur J Radiol 2010; 73: 317-23.
23. Rice SL, Roney CA, Daumar P, Lewis JS. The next generation of positron emission tomography radiopharmaceuticals in oncology. Semin Nucl Med 2011; 41: 265-82.
24. Assouline A, Tai P, Joseph K, Lian JD, Krzisch C, Yu E. Merkel cell carcinoma of skin-current controversies and recommendations. Rare Tumors 2011; 3: e23.
25. Gonzalez RJ, Padhya TA, Cherpelis BS, Prince MD, Aya-Ay ML, Sondak VK, Cruse CW, Zager JS. The surgical management of primary and metastatic Merkel cell carcinoma. Curr Probl Cancer 2010; 34: 77-96.
26. Kukko H, Böhling T, Koljonen V, Tukiainen E, Haglund C, Pokhrel A, Sankila R, Pukkala E. Merkel cell carcinoma - A population-based epidemiological study in Finland with a clinical series of 181 cases. Eur J Cancer 2012; 48(5): 737-42.
27. Poulsen M, Round C, Keller J, Tripcony L, Veness M. Factors influencing relapse-free survival in Merkel cell carcinoma of the lower limb - a review of 60 cases. Int J Radiat Oncol Biol Phys 2010; 76: 393-7.
28. Levy RM, Hanke CW. Mohs micrographic surgery: Facts and controversies. Clin Dermatol 2010; 28: 269-74.
29. Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Kraus DH, Brady MS, Coit DG. Recurrence and survival in patients undergoing sentinel lymph node biopsy for merkel cell carcinoma: analysis of 153 patients from a single institution. Ann Surg Oncol 2011; 18: 2529-37.
30. Howle JR, Hughes TM, Gebski V, Veness MJ. Merkel cell carcinoma: An Australian perspective and the importance of addressing the regional lymph nodes in clinically nodenegative patients. J Am Acad Dermatol 2012; 67(1): 33-40.
31. Schwartz JL, Griffith KA, Lowe L, Wong SL, McLean SA, Fullen DR, Lao CD, Hayman JA, Bradford CR, Rees RS, Johnson TM, Bichakjian CK. Features predicting sentinel lymph node positivity in Merkel cell carcinoma. J Clin Oncol 2011; 29: 1036-41.
32. Stokes JB, Graw KS, Dengel LT, Swenson BR, Bauer TW, Slingluff CL Jr, Ledesma EJ. Patients with Merkel cell carcinoma tumors < or = 1.0 cm in diameter are unlikely to harbor regional lymph node metastasis. J Clin Oncol 2009; 27: 3772-7.
33. Hoetzenecker W, Guenova E, Bottinger TU, Hafner HM, Breuninger H. Mapping of specific sentinel node locations for skin cancer of the head. Eur J Dermatol 2011; 21: 354-8.
34. Pellitteri PK, Takes RP, Lewis JS Jr, Devaney KO, Harlor EJ, Strojan P, Rodrigo JP, Suarez C, Rinaldo A, Medina JE et al. Merkel cell carcinoma of the head and neck. Head Neck 2012; 34(9): 1346-54.
35. Fang LC, Lemos B, Douglas J, Iyer J, Nghiem P. Radiation monotherapy as regional treatment for lymph nodepositive Merkel cell carcinoma. Cancer 2010; 116: 1783-90.
36. Koh CS, Veness MJ. Role of definitive radiotherapy in treating patients with inoperable Merkel cell carcinoma: the Westmead Hospital experience and a review of the literature. Australas J Dermatol 2009; 50: 249-56.
37. Pape E, Rezvoy N, Penel N, Salleron J, Martinot V, Guerreschi P, Dziwniel V, Darras S, Mirabel X, Mortier L. Radiotherapy alone for Merkel cell carcinoma: A comparative and retrospective study of 25 patients. J Am Acad Dermatol 2011; 65: 983-90.
38. Rao NG. Review of the role of radiation therapy in the management of Merkel cell carcinoma. Curr Probl Cancer 2010; 34: 108-17.
39. Veness M, Foote M, Gebski V, Poulsen M. The role of radiotherapy alone in patients with merkel cell carcinoma: reporting the Australian experience of 43 patients. Int J Radiat Oncol Biol Phys 2010; 78: 703-9.
40. Henness S, Vereecken P. Management of Merkel tumours: an evidence-based review. Curr Opin Oncol 2008; 20: 280-6.
41. Clark JR, Veness MJ, Gilbert R, O'Brien CJ, Gullane PJ. Merkel cell carcinoma of the head and neck: is adjuvant radiotherapy necessary? Head Neck 2007; 29: 249-57.
42. Ghadjar P, Kaanders JH, Poortmans P, Zaucha R, Krengli M, Lagrange JL, Ozsoy O, Nguyen TD, Miralbell R, Baize A et al. The essential role of radiotherapy in the treatment of Merkel cell carcinoma: a study from the Rare Cancer Network. Int J Radiat Oncol Biol Phys 2011; 81(4): e583-91.
43. Veness MJ. Merkel cell carcinoma: improved outcome with the addition of adjuvant therapy. J Clin Oncol 2005; 23: 7235-6; author reply 7237-8.
44. Jouary T, Leyral C, Dreno B, Doussau A, Sassolas B, Beylot-Barry M, Renaud-Vilmer C, Guillot B, Bernard P, Lok C et al. Adjuvant prophylactic regional radiotherapy versus observation in stage I Merkel cell carcinoma: a multicentric prospective randomized study. Ann Oncol 2012; 23(4): 1074-80.
45. Foote M, Harvey J, Porceddu S, Dickie G, Hewitt S, Colquist S, Zarate D, Poulsen M. Effect of radiotherapy dose and volume on relapse in Merkel cell cancer of the skin. Int J Radiat Oncol Biol Phys 2010; 77: 677-84.
46. Wobser M, Kurzinger N, Ugurel S, Brocker EB, Becker JC. Therapy of metastasized Merkel cell carcinoma with liposomal doxorubicin in combination with radiotherapy. J Dtsch Dermatol Ges 2009; 7: 521-5.
47. Fakiha M, Letertre P, Vuillez JP, Lebeau J. Remission of Merkel cell tumor after somatostatin analog treatment. J Cancer Res Ther 2010; 6: 382-4.
48. Davids MS, Charlton A, Ng SS, Chong ML, Laubscher K, Dar M, Hodge J, Soong R, Goh BC. Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma. J Clin Oncol 2009; 27: e97-100.
49. Peuvrel L, Quereux G, Brocard A, Renaut JJ, Dreno B. Treatment of a multicentric Merkel cell carcinoma using imatinib. Eur J Dermatol 2011; 21(6): 1009-10.
50. Fields RC, Busam KJ, Chou JF, Panageas KS, Pulitzer MP, Allen PJ, Kraus DH, Brady MS, Coit DG. Recurrence after complete resection and selective use of adjuvant therapy for stage I through III Merkel cell carcinoma. Cancer 2012; 118(13): 3311-20.
51. Mehnert A, Petersen C, Koch U. Empfehlungen zur Psychoonkologischen Versorgung im Akutkrankenhaus. Zeitschrift für Medizinische Psychologie 2003; 12: 77-84.
52. Holland JC, Andersen B, Breitbart W. Distress Management. J Natl Compr Canc Netw 2010; 8: 448-85.
53. Loscalzo M, Clark KL, Holland J. Successful strategies for implementing biopsychosocial screening. Psycho-Oncology 2011; 20: 455-62.
54. Strittmatter G. Psychosoziale Betreuung von Patienten mit Hauttumoren in Zeiten der Diagnosis Related Groups (DRG). Hautarzt 2004; 55: 735-45.